Alum adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alum adjuvant, covering 2025-06-27 to 2025-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Alum Adjuvants in Healthy, HIV-uninfected Adults [Phase 1]